✦ LIBER ✦

Potent antitumor activity of a tumor-specific soluble TCR/IL-2 fusion protein

✍ Scribed by Heather J. Belmont; Shari Price-Schiavi; Bai Liu; Kimberlyn F. Card; Hyung-il Lee; Kai-ping Han; Jinghai Wen; ShaMay Tang; Xiaoyung Zhu; Jane Merrill; Pierre-Andre Chavillaz; Jeffrey L. Wong; Peter R. Rhode; Hing C. Wong

Book ID: 113539416
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 643 KB
Volume: 121
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2006.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting activity of a TCR/IL-2 fusion

Targeting activity of a TCR/IL-2 fusion protein against established tumors

✍ Jinghai Wen; Xiaoyun Zhu; Bai Liu; Lijing You; Lin Kong; Hyung-il Lee; Kai-ping 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 710 KB

Potent antitumoral activity of TRAIL thr

Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins

✍ Schneider, B; Münkel, S; Krippner-Heidenreich, A; Grunwald, I; Wels, W S; Wajant 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 707 KB

Augmented antitumor activity of a second

Augmented antitumor activity of a secondary lymphoid-tissue chemokine (SLC)-interleukin (IL) 2 fusion protein in mouse

✍ Koichiro Nakahara; Tsuneaki Sakata 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

## Abstract ## Background To enhance the antitumor efficacy of IL2 gene therapy, combinations of several other genes, such as p53, a tumor suppressor gene, or lymphotactin, a C‐chemokine, and the IL2 gene are attempted, and synergistic effects are observed. We report here on the enhanced antitumor

A soluble single-chain T-cell receptor I

A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity

✍ KimberlynF. Card; ShariA. Price-Schiavi; Bai Liu; Elizabeth Thomson; Esperanza N 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 509 KB

Exceptionally Potent Anti-Tumor Bystande

Exceptionally Potent Anti-Tumor Bystander Activity of an scFv:sTRAIL Fusion Protein with Specificity for EGP2 Toward Target Antigen-Negative Tumor Cells

✍ Bremer, Edwin; Samplonius, Douwe; Kroesen, Bart-Jan; van Genne, Linda; de Leij, 📂 Article 📅 2004 🏛 Neoplasia Press 🌐 English ⚖ 448 KB

Enhanced tumor delivery and antitumor ac

Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein

✍ Wang, Tao; Hartner, William C.; Gillespie, James W.; Praveen, Kulkarni P.; Yang, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 716 KB